Last reviewed · How we verify
NCT04012320: Bisphosphonate
Efficacy and Safety on the Use of Bisphosphonates in Paediatrics
trial testing No intervention, observational study in Bone Fragile in 99 participants. Completed in 31 December 2018.
31 December 2018
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nīmes |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 99 |
| Start date | 31 October 2018 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- No intervention, observational study
Conditions studied
- Bone Fragile — all drugs for Bone Fragile →
- Bisphosphonate-Associated Osteonecrosis — all drugs for Bisphosphonate-Associated Osteonecrosis →
- Children — all drugs for Children →
- Adverse Events — all drugs for Adverse Events →
Sponsor
Centre Hospitalier Universitaire de Nīmes
Who can join
Under 18, any sex, with Bone Fragile or Bisphosphonate-Associated Osteonecrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators suppose that the impact of bisphosphonate therapy is beneficial on the bone during the growth period with few adverse events.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Outcomes of Clinical Trials on Osteonecrosis of the Jaw.
Wu BW, Lee KC, Halepas S, Karlis V. · · 2021 · PMID 34660159 · DOI 10.7759/cureus.17984
Verify or expand the search:
- PubMed search for NCT04012320
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention, observational study
Trials testing the same drug.
- NCT06069973 — Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia · recruiting
- NCT05239299 — Treatment Options for Pediatric Chronic Pain: How do we Best Disseminate Our Scientific Findings · completed
- NCT05443711 — Sarcopenic Obesity as a Risk of Premature Aging · unknown
- NCT04863846 — Evidence-based Algorithm for the Expected Difficult Intubation · completed
- NCT06221982 — TIPS for PH Patients: an Observational, Cohort Study · unknown
Other Centre Hospitalier Universitaire de Nīmes trials
Trials by the same sponsor.
- NCT07403474 — Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Ther · Phase 4 · not yet recruiting
- NCT07455981 — Work Organization and Gambling Addiction · not yet recruiting
- NCT07403500 — Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain. · NA · not yet recruiting
- NCT07342010 — Bicarbonate Addition to Lidocaine-Epinephrine in Surgery Under WALANT · Phase 4 · not yet recruiting
- NCT07305727 — A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04012320 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nīmes
- Last refreshed: 9 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04012320.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing